Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrija Bogdanovic

Showing results (11-20 of 51) with videos related to

Pageof 6
Sort By:
Internal Medicine (Tokyo, Japan)|March 20, 2015
Diagnostic challenges during pretreatment long-term follow-up in a patient with FIP1L1-PDGFRA-positive eosinophiliaDanijela Lekovic, Andrija Bogdanovic, Maja Perunicic-Jovanovic, et al.
Hamostaseologie|September 20, 2021
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal HaemoglobinuriaZlatko Pravdic, Mirjana Mitrovic, Andrija Bogdanovic, et al.
Medical Oncology (Northwood, London, England)|February 2, 2013
International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemiaMirjana Mitrovic, Nada Suvajdzic, Andrija Bogdanovic, et al.
Hematology (Amsterdam, Netherlands)|March 23, 2017
Predictive parameters for imatinib failure in patients with chronic myeloid leukemiaDanijela Lekovic, Mirjana Gotic, Natasa Milic, et al.
European Journal of Haematology|May 7, 2014
A single institution experience on 314 newly diagnosed advanced Hodgkin lymphoma patients: the role of ABVD in daily practiceBosko Andjelic, Darko Antic, Ljubomir Jakovic, et al.
Expert Review of Hematology|June 16, 2025
Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methodsIsidora Arsenovic, Natasa Milic, Nikola Grubor, et al.
Journal of Clinical Medicine|August 10, 2024
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic ImplicationsIvan Krecak, Danijela Lekovic, Isidora Arsenovic, et al.
Annals of Hematology|May 13, 2006
A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro)Tatjana Pekmezovic, Nada Suvajdzic Vukovic, Darija Kisic, et al.
Medical Oncology (Northwood, London, England)|February 7, 2014
Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosisDanijela Lekovic, Mirjana Gotic, Maja Perunicic-Jovanovic, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-RMarijana Virijevic, Ljubomir Jakovic, Lazar Trajkovic, et al.
Pageof 6

Showing results (11-20 of 51) with videos related to

Sort By:
Pageof 6
Internal Medicine (Tokyo, Japan)|March 20, 2015
Diagnostic challenges during pretreatment long-term follow-up in a patient with FIP1L1-PDGFRA-positive eosinophiliaDanijela Lekovic, Andrija Bogdanovic, Maja Perunicic-Jovanovic, et al.
Hamostaseologie|September 20, 2021
COVID-19 Presented with Deep Vein Thrombosis in a Patient with Paroxysmal Nocturnal HaemoglobinuriaZlatko Pravdic, Mirjana Mitrovic, Andrija Bogdanovic, et al.
Medical Oncology (Northwood, London, England)|February 2, 2013
International Society of Thrombosis and Hemostasis Scoring System for disseminated intravascular coagulation ≥ 6: a new predictor of hemorrhagic early death in acute promyelocytic leukemiaMirjana Mitrovic, Nada Suvajdzic, Andrija Bogdanovic, et al.
Hematology (Amsterdam, Netherlands)|March 23, 2017
Predictive parameters for imatinib failure in patients with chronic myeloid leukemiaDanijela Lekovic, Mirjana Gotic, Natasa Milic, et al.
European Journal of Haematology|May 7, 2014
A single institution experience on 314 newly diagnosed advanced Hodgkin lymphoma patients: the role of ABVD in daily practiceBosko Andjelic, Darko Antic, Ljubomir Jakovic, et al.
Expert Review of Hematology|June 16, 2025
Thrombo-vera: a new thrombosis risk model for polycythemia vera using modern variable selection methodsIsidora Arsenovic, Natasa Milic, Nikola Grubor, et al.
Journal of Clinical Medicine|August 10, 2024
Systemic Inflammatory Index in Polycythemia Vera and Its Prognostic ImplicationsIvan Krecak, Danijela Lekovic, Isidora Arsenovic, et al.
Annals of Hematology|May 13, 2006
A case-control study of myelodysplastic syndromes in Belgrade (Serbia Montenegro)Tatjana Pekmezovic, Nada Suvajdzic Vukovic, Darija Kisic, et al.
Medical Oncology (Northwood, London, England)|February 7, 2014
Contribution of comorbidities and grade of bone marrow fibrosis to the prognosis of survival in patients with primary myelofibrosisDanijela Lekovic, Mirjana Gotic, Maja Perunicic-Jovanovic, et al.
Medicina (Kaunas, Lithuania)|September 27, 2025
Improving MDS Risk Assessment: The Role of Monocytopenia and Lymphocytopenia Beyond IPSS-RMarijana Virijevic, Ljubomir Jakovic, Lazar Trajkovic, et al.
Pageof 6